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Abstract 13 
Reproductive management in cattle requires the synchrony of follicle development and oestrus 14 
prior to insemination. However, the ovulation of follicles that have not undergone normal 15 
physiological maturation can lead to suboptimal luteal function. Here we investigated the 16 
expression of a targeted set of 47 genes in (a) a first-wave vs final-wave dominant follicle (DF; 17 
the latter destined to ovulate spontaneously), and (b) 6-day old corpora lutea (CLs) following 18 
either spontaneous ovulation, or induced ovulation of a first-wave DF, to ascertain their 19 
functional significance for competent CL development. Both the mass and progesterone 20 
synthesising capacity of a CL formed following induced ovulation of a first-wave DF were 21 
impaired. These impaired CLs had reduced expression of steroidogenic enzymes (e.g. STAR and 22 
HSD3B1), luteotrophic receptors (LHCGR) and angiogenic regulators (e.g. VEGFA), and 23 
increased expression of BMP2 (linked to luteolysis). Relative to final-wave DFs, characteristic 24 
features of first-wave DFs, included reduced oestradiol concentrations and a reduced 25 
oestradiol:progesterone ratio in the face of increased expression of key steroidogenic enzymes 26 
(i.e. CYP11A1, HSD3B1 and CYP19A1) in granulosa cells; and reduced expression of the HDL 27 
receptor SCARB1 in thecal cells. Transcripts for further components of the TGF and IGF systems 28 
(e.g. INHA, INHBA, IGF2R and IGFBP2) varied between first- and final-wave DFs. These results 29 
highlight the importance of hormones such as progesterone interacting with local components of 30 
both the TGF and IGF systems to affect the maturation of the ovulatory follicle and functional 31 
competency of the subsequent CL.  32 
           33 
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Introduction   34 
 35 
Since the introduction of ovulation synchronization into mainstream reproductive management of 36 
cattle (Pursley et al., 1995) a plethora of studies have examined in detail the benefits of follicle 37 
synchrony in reproductive management programs (Bisinotto et al., 2014; Wiltbank and Pursley, 38 
2014). However, it has been shown that ovulation of follicles that have not undergone normal 39 
physiological maturation can lead to suboptimal luteal function compared to spontaneous 40 
ovulation. For example, following synchronization Perry et al. (2005) found that ovulation of 41 
smaller follicles (presumed to be short of full maturity) resulted in decreased pregnancy rates. 42 
This was associated with lower oestradiol (E2) on the day of insemination together with impaired 43 
subsequent luteal function. In contrast, they reported no effect of ovulatory follicle size when 44 
ovulation occurred spontaneously. Furthermore, Bisinotto et al. (2010) found differences in 45 
pregnancy rate following artificial insemination (AI) according to wave of the ovulated follicle, 46 
with higher pregnancy rates following ovulation of a second than a first wave dominant follicle 47 
(DF). However, less is known about the impact of ovulatory control programs on the detailed 48 
molecular control mechanisms underpinning the adequacy of the ovulatory follicle and resulting 49 
corpus luteum (CL). 50 
The expression of several genes involved with ovulation, luteinisation and CL function is under 51 
endocrine control. Production of the prostaglandin PGF2α, for instance, has been shown to be 52 
regulated by progesterone (P4) (Sharzynski and Okuda, 1999; Okuda et al., 2004). A first wave 53 
DF undergoes selection during a period of low circulating P4 whereas, during later follicular 54 
waves, DF selection occurs during the luteal phase of the oestrous cycle in the presence of higher 55 
concentrations of circulating P4 (Savio et al., 1988; Ginther et al., 1989). There is evidence that 56 
P4 supplementation prior to induced ovulation (around the time of ovulatory DF selection) can 57 
increase pregnancy per AI (Wiltbank et al., 2011; Colazo et al., 2013), which is likely due to the 58 
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beneficial effects of P4 supplementation on the development of the first wave DF (Bisinotto et 59 
al., 2010). 60 
With the foregoing discussion in mind, our hypothesis was that the hormonal milieu within which 61 
a DF develops affects its ability to form a viable CL, that this is related to the expression of genes 62 
with key roles in regulating DF development, subsequent luteinisation and CL function, and that 63 
the expression of these genes differs between first and final wave DFs. It was also hypothesised 64 
that the CL formed following induced ovulation of a first wave DF would be smaller and less 65 
capable of P4 production than those formed following spontaneous ovulation, and that this would 66 
be associated with altered expression of genes involved in cellular differentiation, tissue growth 67 
and steroidogenesis.   68 
To test these hypotheses we conducted an experiment which involved 24 cyclic virgin heifers 69 
where we compared the expression of a targeted set of genes (Table 1), with established 70 
physiological effects within the bovine ovary, in follicles and CLs of differing size at contrasting 71 
stages of the oestrous cycle. Specifically, we wanted to compare the molecular characteristics of 72 
(a) a first-wave DF to that of a final-wave DF destined to ovulate spontaneously, and (b) a 6-day 73 
old CL following spontaneous ovulation to a 6-day old CL following induced ovulation of a first-74 
wave DF. These data were related to quantitative measures of steroidogenesis and local and 75 
systemic growth factor and hormone concentrations.  76 
 77 
Materials and Methods 78 
 79 
Sample Collection 80 
Twenty-four post-pubertal Hereford x Holstein heifers (mean ± SEM live weight of 417.5 ± 7.3 81 
kg and body-condition score (BCS) of 2.53 ± 0.05 units; Lowman et al. (1976)) were allocated to 82 
one of three treatment groups (A-C) according to live weight and BCS, giving eight animals per 83 
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treatment. Animals were group housed on straw bedding and given ad libitum access to water and 84 
hay. Mineralised concentrates were given twice daily at a rate of 5 kg per animal per day, rising 85 
to 6 kg as the animals gained weight in line with their metabolisable energy and protein 86 
requirements (AFRC, 1993). All procedures were performed under the auspices of the Animal 87 
Scientific Procedures Act (1986) and approved by the University of Nottingham ethical review 88 
committee. 89 
Oestrous cycles were synchronised initially using two intra-muscular prostaglandin (PG) 90 
injections (2 ml Estrumate; Intervet UK Ltd., Milton Keynes, UK) given 11 days apart. An intra-91 
muscular injection of GnRH (2.5 ml Receptal; Intervet UK Ltd., Milton Keynes, UK) was given 92 
48 hours after the initial dose of PG (Figure 1). Timing of ovulation was confirmed by transrectal 93 
real time B-mode ultrasonography using an Aloka SSD-500v scanner (Aloka Co. Ltd., Tokyo, 94 
Japan) equipped with a 5-MHz linear array on nominal Day -1 and +1 of the anticipated day of 95 
ovulation. We (Sinclair and Mann, unpublished data) have previously observed that trans-rectal 96 
ovarian ultrasonography on the expected day of ovulation can delay or inhibit this event in some 97 
animals. Heifers in group A were slaughtered on Day 6 after synchronised ovulation (Day 0) to 98 
recover a first-wave DF and a 6-day old, spontaneous CL. Animals in group B were given 5 ml 99 
GnRH and 2 ml PG on Day 6 to cause ovulation of the first-wave DF and regression of the 100 
spontaneous CL, then slaughtered on Day 13 to retrieve a 6-day old, induced CL and a DF. 101 
Animals in group C were given 2 ml PG on Day 18 and slaughtered on Day 19 to retrieve a final-102 
wave DF and a regressing CL. All animals were blood sampled daily by jugular venipuncture and 103 
samples were analysed for plasma P4 and insulin-like growth factor 1 (IGF-1). Additional blood 104 
samples were taken from group B at 0, 1 and 2 hours after GnRH injection on Day 6 for plasma 105 
LH analysis. To monitor ovarian follicular development and to confirm cyclicity, animals in 106 
group C underwent transrectal ultrasonography daily, except on the day of expected ovulation. 107 
All other animals underwent transrectal ultrasonography on the days prior to and following 108 
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expected ovulations (including that following initial synchronisation; Day 0) and on the day prior 109 
to slaughter. 110 
Animals were blood sampled prior to transportation to an on-site abattoir for slaughter. Ovaries 111 
from each animal were recovered, transferred to the laboratory within 10 minutes of slaughter 112 
and processed immediately. The largest follicle (≥ 11 mm) was dissected from each pair of 113 
ovaries. Follicular fluid was aspirated from this large follicle (presumed to be a DF), the largest 114 
subordinate follicle (SF) and a selection of smaller subordinate follicles (2-6 mm) from each pair 115 
of ovaries and stored at -20
o
C. Granulosa cells were then scraped from the DF and washed in 116 
PBS before storage at -80
o
C in RLT+ lysis buffer (Qiagen, Crawley, UK). The thecal sheet was 117 
then peeled away from the DF wall using a pair of fine forceps, washed in PBS and stored at        118 
-80
o
C in RLT+ lysis buffer (Qiagen, Crawley, UK). 119 
CLs were dissected from ovaries, measured, weighed and then divided into three sections. The 120 
first section was minced using a scalpel blade, washed in PBS then centrifuged at 1,500 g for 3 121 
minutes. RLT+ lysis buffer (Qiagen, Crawley, UK) was added to the cell pellet, which was stored 122 
at -80
o
C to be homogenised immediately prior to RNA extraction. The second section was 123 
minced and washed in PBS then divided further to give three 25 mg (± 2 mg) samples per animal, 124 
which were snap frozen in liquid nitrogen and stored at -80
o
C prior to P4 analysis by ELISA. The 125 
third section was also minced, washed and divided to give three 25 mg (± 2mg) samples per 126 
animal. These samples were re-suspended in 2 ml culture medium (M199 containing 0.068 mM 127 
L-glutamine) and incubated at 38
o
C for 30 min in a shaking water bath at 70 strokes per minute. 128 
They were then centrifuged at 1,500g for 5min and the tissue and spent media snap frozen 129 
separately in liquid nitrogen and stored at -80
o
C prior to P4 analysis by ELISA. 130 
Hormone Assays 131 
A commercially available ELISA kit (Ridgeway Science, St. Briavels, UK) was used to measure 132 
P4 in follicular fluid, blood plasma, spent culture media and CL extracts as previously described 133 
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(Wonnacott et al., 2010). CL tissue samples were ethanol extracted prior to P4 assay. 5 ml 134 
double-distilled ethanol was added to each sample, on ice. The samples were homogenised for 30 135 
seconds (Polytron PT400; Kinematica, Lucerne, Switzerland), evaporated to dryness using a 136 
speedvac (Savant DNA 110; Thermo Fisher Scientific, Cramlington, UK) and then re-dissolved 137 
in 1 ml PBS. Plasma standards and quality controls (QCs) (Ridgeway Science, St. Briavels, UK) 138 
were used when analysing blood plasma samples and buffer standards and QCs (Ridgeway 139 
Science, St. Briavels, UK) were used when analysing all other samples, with intra- and inter-140 
assay coefficients of variation of 6.69% and 5.68%, respectively. 141 
Oestradiol was measured by radioimmunoassay, as previously described (Kanakkaparambil et al., 142 
2009). The intra- and inter-assay coefficients of variation for this assay were 4.63% and 11.63% 143 
respectively. A commercially available bovine ELISA kit (LH Detect; ReproPharm, France) was 144 
used to measure LH in blood plasma. The intra- and inter-assay coefficients of variation for this 145 
assay were 5.49% and 15.24% respectively. 146 
A commercially available kit was used to measure IGF1 in blood plasma (DRG Instruments 147 
GmbH, Marburg, Germany) from day 0 and the day of slaughter (refer to Figure 1). No sample 148 
dilution was necessary. The intra- and inter-assay coefficients of variation for this assay were 149 
4.43% and 7.21% respectively. 150 
Transcript Expression  151 
RNA extraction was performed using a commercially available kit (RNeasy mini kit; Qiagen, 152 
Crawley, UK) and RNA concentration was determined using a NanoDrop ND-1000 UV-vis 153 
spectrophotometer (Thermo Fisher Scientific, Cramlington, UK). Samples were diluted in RNase 154 
free water to a concentration of 20 ng/µl prior to a further gDNA removal step using another 155 
commercially available kit (TURBO DNA-free; Ambion, Huntingdon, UK). mRNA was 156 
denatured at 70
o
C for 10 min using a thermal cycler (BioRad, Hemel-Hempstead, UK) prior to 157 
RT and subsequent transcript expression analysis. 158 
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Expression of 47 genes (Table 1A) known to regulate DF and CL function was quantified using 159 
the GenomeLab GeXP Genetic Analysis System (Beckman Coulter Inc., High Wycombe, UK). 160 
This method utilises gene specific primers that have a universal sequence tag. Forward universal 161 
primers within the PCR buffer are fluorescently labelled, allowing detection and quantification of 162 
up to 30 size separated products within a single PCR reaction (Wu et al., 2008; Rai et al., 2009). 163 
Transcripts were divided arbitrarily between two multiplex reactions. Due to the size and relative 164 
importance of the LHCGR transcript in ovulation and luteinisation, a separate multiplex reaction 165 
was designed to amplify several regions of the mRNA (Table 1b). 166 
RT-PCR reactions were performed using reagents (including an internal standard) and software 167 
provided by Beckman Coulter Inc. (High Wycombe, UK). For each of three different multiplex 168 
reactions, reverse primers (Sigma-Genosys Ltd., Poole, UK) were mixed together at 169 
concentrations ranging from 60 to 1,500 nM in 10 mM Tris-HCl solution, pH 8.0 (Sigma-170 
Aldrich, Poole, UK) and forward primers (Sigma-Genosys Ltd., Poole, UK) were mixed together 171 
at a concentration of 200 nM each using the same solution. Reverse primer concentrations were 172 
adjusted to allow for variation in initial concentrations of mRNA templates and primer 173 
efficiencies.  Forward primers contained universal sequence tags used for amplification after the 174 
first few cycles of PCR. For primer sequences see Tables 1A and 1B. RT was carried out 175 
including the mixture of reverse primers, and 35 cycles of PCR were carried out including the 176 
mixture of forward primers, as per the manufacturer’s instructions. The resulting PCR products 177 
were diluted 1:30 in water and 2µl of diluted sample was mixed with 0.5µl DNA size standard-178 
400 and 37.5µl sample loading solution in an appropriate well of a 96-well electrophoresis plate 179 
and covered with mineral oil. The plate was then placed in a GeXP Genetic Analysis System 180 
which separates the PCR products by capillary electrophoresis.  181 
Data was checked using the fragment analysis module of the GenomeLab GeXP system software 182 
and any samples lacking a peak from the internal standard, Kan
r
, were repeated. The fragment 183 
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data and peak area was then imported into the eXpress Analysis module of eXpress Profiler 184 
software, where fragments are linked with gene information giving expression, in arbitrary 185 
fluorescence units, for each transcript within each well. This was then exported into Microsoft 186 
Excel and transcript expression was normalised within each sample by dividing the target 187 
expression by the average expression of the three control genes, giving target expression relative 188 
to GAPDH, H2AZ and RPLP0 in relative fluorescence units. Although the GeXP multiplex 189 
technology is tried and tested, by way of validation in our hands we compared expression of a 190 
number of genes using quantitative real-time PCR and GeXP (Supplementary Figure 1). 191 
Western Blotting  192 
In support of the transcript data that emerged from this study, and given that the follicular fluids 193 
collected were committed fully to steroid analyses, additional pairs of bovine ovaries were 194 
collected from a local abattoir, retaining individual animal identity, and classified according to 195 
stage of the oestrous cycle by assessing gross morphology of the CL, based on the observations 196 
and classification of Ireland et al. (1980). Pairs of ovaries presenting healthy, non-atretic follicles 197 
were classified as originating from either the early follicular- or early luteal-phases. The largest 198 
follicle (10-14 mm) per pair of ovaries was dissected, aspirated and granulosa cells scraped and 199 
washed as described previously.  200 
Follicular fluid samples (5 µl), in Laemmli buffer were subjected to electrophoresis on 10% SDS-201 
polyacrylamide gels. Proteins were blotted onto nitrocellulose membrane (Optitran BA-S 83, 202 
Schleicher & Schuell). Membranes were incubated for 60 min at 21
o
C with blocking solution 203 
(PBS, pH 7.4 with 0.05% Tween-20 and 3% non-fat milk powder) and then incubated overnight 204 
at 4
o
C in the same solution containing the specific primary antiserum (rabbit anti-IGFBP-2, 205 
Upstate Biotechnology) diluted 1:1500. The membranes were washed three times with PBS-206 
Tween and then incubated with HRP-labelled anti-rabbit IgG (BioRad) diluted 1:25000 in 207 
blocking solution for 60 min at 21
o
C. Membranes were washed twice for ten minutes with PBS-208 
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Tween and once with PBS. The bands were visualised using enhanced chemiluminescence (ECL, 209 
GE Healthcare) and detected on BioMax Light film (Carestream). Bands were quantified using 210 
Image J software.  211 
Statistical analysis 212 
All statistical analysis was performed using Genstat version 11.1.0.1504 (VSN International Ltd., 213 
Hemel-Hempstead, UK). Necessary transformations of P4 and E2 data were determined by Box-214 
Cox analysis. Analysis of variance (ANOVA) was used to compare E2 concentrations, P4 215 
concentrations, and gene expression between stages of the oestrous cycle. DF size, CL weight 216 
and CL size were also compared by ANOVA. For transcript analyses a common approach in 217 
simultaneous testing is the Benjamini and Hochberg linear step-up false discovery rate (FDR) 218 
controlling procedure (Reiner et al., 2003). For such data an FDR of 0.25 (q) is typically applied 219 
to avoid a high proportion of false negatives. P values (P(1) ≤ … ≤ P(m)) were ordered along with 220 
their respective null hypotheses (H(1), …, H(m)), and ranked Pi were compared to the critical value 221 
q.i/m. In this analysis k = max i for which Pi ≤ q.i/m. We then rejected H(1), …, H(k).  Treatment 222 
comparisons were then made using the least significant difference test. 223 
 224 
Results 225 
 226 
Ovarian follicle and CL development 227 
Shortly after the onset of oestrous synchrony (i.e. Day -13, Figure 1A), ultrasound scanning 228 
confirmed that a CL was present in all 8 heifers allocated to Group A, 6/8 heifers allocated to 229 
Group B, and 6/8 heifers allocated to Group C. Ultrasound scanning on Day -13 (one day prior to 230 
GnRH) further confirmed the presence of follicles ≥ 8 mm in diameter in all 24 heifers (size 231 
range 8 to 18 mm). One of the two heifers in Group B that didn’t have a CL present at the onset 232 
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of synchrony subsequently failed to ovulate at Day 0 (Figure 1A), so this animal was removed 233 
from any further analysis. All other animals ovulated between 11 am on Day -1 and 11 am on 234 
Day +1 as expected, and diameter of the ovulatory follicle (i.e. its last recorded diameter as 235 
determined by ultrasound scanning) did not differ between groups (mean ± SEM of 13.4 ± 2.62 236 
mm). Similarly, DF and CL diameter on Day 5 did not differ between groups (mean values of 237 
11.6 ± 2.02 mm and 18.7 ± 4.32 mm respectively). Plasma P4 concentrations were also found not 238 
to differ between groups prior to Day 6 (Figure 1B). Of the seven animals remaining in Group B, 239 
all underwent luteal regression, resulting in a decrease in plasma P4 (Figure 1B), and ovulated 240 
between 11 am on Day 6 and 11 am on Day 8. Response to GnRH was supported by an 241 
immediate increase  (P<0.001) in plasma LH (from 1.0 ± 0.64 pg/ml at the time of GnRH 242 
administration to 8.7 ± 0.83 ng/ml two hours later), followed by disappearance of the DF within 243 
48 h. Ovulatory-follicle diameter was compared between the initial, synchronised ovulation 244 
(Groups A, B and C; Day 0) and induced ovulation (Group B; Day 7), but no significant 245 
difference was detected (13.4 vs 12.0 mm (P=0.09) measured on Days -1 and 6 respectively; 246 
Supplementary Figure 3A). Furthermore, when it came to slaughter there was no difference in DF 247 
diameter between groups (Table 2A). However, CLs collected from Group B at slaughter were 248 
smaller (P = 0.021) and weighed less (P = 0.049) than those collected from group A (Table 2A).  249 
Of the 8 heifers in Group C, 3 had a two-wave cycle, 4 had a three-wave cycle, and one had a 250 
four-wave cycle. For DFs at slaughter in these animals, the time interval from initial visualisation 251 
(≤ 2 mm) to slaughter was 8.25 ± 0.48 vs 6.0 ± 0.57 days (P = 0.024) for two- and three-wave 252 
cycles respectively. There was no significant difference in diameter of the DF between two- vs 253 
three-wave cycles (15.5 ± 1.29 vs 14.0 ± 2.16 mm). Similarly, there was no difference in FF 254 
steroid concentrations between these two groups (E2: 402 ± 172 vs 412 ± 156 ng/ml.  P4: 69 ± 13 255 
vs 83 ± 46 ng/ml).  256 
CL progesterone producing capacity 257 
Page 11 of 49
reproduction@bioscientifica.com
Manuscript submitted for review to Reproduction
For Review Only
12 
 
Total P4 content (amount of P4 per CL), P4 production (amount of P4 produced per unit of tissue 258 
cultured = P4tissue + P4media – P4initial tissue) and P4 synthetic capacity (P4 production corrected for 259 
total CL weight) were greater (P = 0.035, < 0.001 and < 0.001 respectively) for Group A than for 260 
either Groups B or C (Table 2A). Furthermore analyses indicated that diameter of the follicle 261 
destined to ovulate was positively (P = 0.001) correlated with diameter of the resulting CL six 262 
days after ovulation for DFs scanned on Day -1, but not for DFs scanned on Day 6 (i.e. Group B) 263 
(Supplementary Figure 3A). However, diameter of the resulting CL was not correlated with its P4 264 
synthetic capacity for either Group A or B treatments (Supplementary Figure 3B), indicating that 265 
size of these structures alone does not explain CL functionality.  266 
Follicular fluid hormone concentrations 267 
As one might expect, follicular-fluid P4 concentration was greater (P<0.05) in small follicles than 268 
in DFs, and E2 concentration was greater (P < 0.001) in DFs than in small follicles (Table 2B). 269 
There was a strong indication (P = 0.058) that P4 concentrations were greater in small follicles 270 
from Group A than in small follicles from Groups B and C. There was also a strong indication (P 271 
= 0.056) that E2 concentrations were lower in follicular fluids from DFs in Group A than in 272 
follicular fluids from either Groups B or C. This observation was supported by a lower (P = 273 
0.054) E2:P4 ratio in DF fluids from Group A compared to Groups B and C.   274 
Transcript expression 275 
Transcripts for AMH, BMP2, BMP6, ESR1, FGF1, IGF2, CYP17A1, IL2, IL6, MIF and PGR 276 
were not detected in granulosa cells. Similarly transcripts for AMH, BMP2, BMP6, FGF1, 277 
CYP19A1, IL2, IL6, MIF and VEGFA mRNA were not detected in thecal cells; and transcripts for 278 
AMH, BMP6, FGF1, IL2, IL6, INHA, LRP8 and PGR mRNA were not detected within the CL. 279 
Although expressed in our mixed population of ovarian cells during GeXP platform development, 280 
the following genes were not expressed in any of our experimental cell types: AMH, BMP6, 281 
FGF1, IL2 and IL6 (see Supplementary Materials and Results). 282 
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In granulosa cells, expression of INHA, INHBA, CYP11A1, CYP19A1, ESR2, HSD3B1, HIF1A 283 
and PGF2AR was greater (P < 0.05) in Group A (first wave DF) than Group C (final wave DF) 284 
(Table 3A). In thecal cells, expression of IGF2R, IGFBP2, SCARB1 and PTPRC was lower (P < 285 
0.05) for Group A than for Group C (Table 3B). Interestingly, thecal cell SCARB1 expression was 286 
lower (P < 0.05) in Group A than Group B, and expression of PGF2AR was only detectable in 287 
thecal cells from Group B (data not shown). LHCGR splice variant expression within granulosa 288 
and also thecal cells of the DF did not differ with stage of the oestrous cycle. 289 
Many more of our selected transcripts were differentially expressed in the CL (Table 4) than in 290 
either granulosa or thecal cells (Table 3). For the CL, the greatest differences in transcript 291 
expression were between Groups A and C; transcript expression for Group B often was 292 
intermediate to these contrasting levels. Given that the comparison of particular interest lies 293 
between Groups A and B, it is noteworthy that BMP2 and IGFBP5 expression was lower in CLs 294 
from Group A than from Group B. In contrast, expression of IGFBP4, HSD3B1, STAR, KITLG, 295 
GADD45B, VEGFA, PGF2AR, LHCGRex2, -ex2(-3), -ex8 and –ex8(-9) was greater for Group A 296 
than Group B.   297 
Plasma IGF1 concentration 298 
At Day 0 (see Figure 1), plasma IGF1 concentration was 148 ± 47 ng/ml and did not differ 299 
between treatment groups. At the point of slaughter, however, plasma IGF1 was significantly 300 
lower (P = 0.001) in heifers from Group A than from Groups B and C (Figure 2). 301 
IGF2R and IGFBP2 expression in supplementary abattoir ovaries  302 
In granulosa cells harvested from cycle-stage determined abattoir-derived ovaries, relative 303 
expression of IGF2R and IGFBP2 was greater (P = 0.004) in cells from early follicular-phase 304 
(similar to Group C) than early luteal-phase (similar to Group A) dominant follicles (0.267 ± 305 
0.022 vs 0.188 ± 0.018 for IGF2R; 0.631 ± 0.060 vs 0.353 ± 0.050 for IGFBP2). In agreement 306 
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with transcript abundance, the concentration of IGFBP2 protein in follicular fluid was greater (P 307 
< 0.001) from early follicular- than early luteal-phase DFs (Figure 3). 308 
 309 
Discussion 310 
 311 
This study reports a number of key findings. Both the mass and P4 synthesising capacity of a CL 312 
formed following induced ovulation of a first-wave DF (i.e. CLs from Group B in this study) 313 
were reduced relative to a CL formed following spontaneous ovulation (i.e. CLs from Group A). 314 
Indeed, the P4 synthetic capacity of these induced (i.e. Group B) CLs was similar to that of a 315 
regressing CL (i.e. Group C) during the pro-oestrous phase of the cycle and, at a molecular level, 316 
they were characterised as having reduced expression of steroidogenic enzymes (i.e. STAR and 317 
HSD3B1) involved in cholesterol transfer into mitochondria and conversion of pregnenolone to 318 
progesterone. These induced CLs were further characterised as having reduced expression of 319 
LHCGR (required for luteal support; Niswender et al., 2007) and VEGFA (a key angiogenic 320 
regulator; Robinson et al., 2007), together with increased expression of BMP2 (linked to 321 
luteolysis in regressing CLs; Nio-Kobayashi et al., 2015).  322 
Regarding follicular development, relative to final wave DFs (i.e. those from Group C at Day 19), 323 
key functional features of first wave DFs (i.e. those from Group A at Day 6, coinciding with 324 
GnRH treatment in Group B) included reduced E2 concentrations and a reduced E2:P4 ratio. 325 
These differences occurred in the face of increased transcript expression of key steroidogenic 326 
enzymes (i.e. CYP11A1 (encoding cholesterol side-chain cleavage), HSD3B1 and CYP19A1 327 
(encoding aromatase)) in granulosa cells; and reduced expression of SCARB1 (which facilitates 328 
cellular cholesterol uptake from high-density lipoproteins; Azhar et al., 1998) in thecal cells. Also 329 
different between these two DF groups were transcripts for two inhibin/activin subunits (i.e. 330 
INHA and INHBA), which were both increased in first wave relative to final wave DFs. 331 
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Importantly, given that background plasma and follicular-fluid P4 levels were similar between 332 
Groups A and B (Figure 1B and Table 2B), it is noteworthy that transcript expression for a range 333 
of genes in granulosa and thecal cells from both Groups A and B were also similar, highlighting 334 
the importance of P4 as a regulator of follicular maturation. Finally, it is also worth noting the 335 
differences in transcript expression of IGF2R and IGFBP2 in both granulosa and thecal cells, and 336 
protein expression of IGFBP2 in follicular fluid, between first- and final-wave DFs (i.e. Group A 337 
vs Group C). These were consistently lower in first- relative to final-wave DFs, when circulating 338 
levels of IGF1 were also at their lowest (Figure 3). These differences seem to be of key 339 
significance given that these IGF family members each serve to regulate the bioavailability of 340 
both IGF-1 and -2 within the ovarian follicle (Webb and Campbell, 2007). However, the issue of 341 
proximity to PG administration cannot be discounted. Indeed, PGF2AR expression was lower in 342 
Group C ovarian cells (i.e. granulosa and luteal) than in Group A, with Group B in between. This 343 
could be due to direct or indirect actions of PG. 344 
Collectively, these results indicate an important role of P4 during terminal follicle maturation that 345 
determines subsequent luteal competence, although the effects of endogenous LH, which are well 346 
established (e.g. Qunintal-Franco et al., 1999) but not determined in this study, and differences in 347 
the nature and timing of pharmacological intervention (i.e. PG relative to endogenous or 348 
administered GnRH) between groups cannot be discounted. Indeed, in sheep Murdoch and Van 349 
Kirk (1998) found that premature induction of ovulation (i.e. 12 h vs 36 h after PG-induced 350 
luteolysis) compromised the formation of a functionally competent CL. In the current study, 351 
follicles that gave rise to less competent CLs were less oestrogenic than those that gave rise to 352 
more competent CLs, and the data point to underlying contributions by components of both the 353 
TGF and IGF systems. 354 
The ‘final-wave’ dominant follicle 355 
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In the current study one could consider the DF that ovulated around Day 0 to be representative of 356 
a ‘final wave’ DF, although it is recognised that this follicle did not occur in a natural, 357 
uncontrolled oestrous cycle, but rather in one where both follicle and CL development were 358 
regulated and synchronised (Figure 1). This was necessary for experimental purposes as it 359 
standardised follicle development to a more precisely timed ovulation. From the perspective of 360 
assisted reproduction, it is also representative of protocols routinely used for oestrous 361 
synchronisation. Furthermore, ovulation of the resultant DF was induced by the endogenous 362 
surge of LH that followed the second prostaglandin treatment; and thus more closely resembles 363 
the natural ovulatory pr cess than that represented by the GnRH-induced ovulation of a Day 6 364 
DF. However, this ‘final-wave’ DF (i.e. destined to ovulate around Day 0) probably developed 365 
under a low P4 environment (not determined), given that PG administration preceded GnRH 366 
treatment during the initial synchrony programme (Figure 1 A).  In contrast, the DFs harvested 367 
from Group C heifers on Day 19 (24 h after PG) better represent the normal final-wave, pre-368 
ovulatory follicle.  369 
Corpus luteum 370 
In bovine assisted reproduction, either follicle ablation or aspiration (to recover ova) close to the 371 
anticipated time of ovulation leads to the formation of small CLs, with reduced capacity to 372 
produce and secrete P4 (O’Hara et al., 2012). This reduction in P4 secretion is, in turn, associated 373 
with reduced expression of LHCGR in luteal tissue. These authors commented that this may be 374 
due in part to removal of a variable number of granulosa cells that would otherwise have 375 
contributed to luteal formation; although given the preferential localisation of LHCGR to small 376 
(i.e. theca derived) luteal cells (Yuan and Lucy, 1996; Mamluk et al., 1998) it is uncertain if this 377 
alone could account for reduced LHCGR expression. The study of Hayashi et al. (2006), 378 
however, highlighted the importance of appropriate LH priming prior to GnRH induced ovulation 379 
for the formation of functionally competent CLs. In the current study, DFs from Group C best 380 
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represent ‘final-wave’ (pre-ovulatory) DFs, but the timing of their collection (i.e. 24 h post PG 381 
administration; Figure 1) probably precluded exposure to surge levels of LH. In contrast, the 382 
‘final-wave’ DF that gave rise to a Day 6 CL (Group A) will probably have been ‘older’ and 383 
larger at the point of ovulation, and almost certainly would have been exposed to higher levels of 384 
LH; although these parameters were not determined. Therefore, whilst molecular features of 385 
Group C relative to Group A DFs (discussed later) provide important information on factors 386 
regulating subsequent CL function, they probably don’t represent the complete picture.  387 
Molecular basis of luteal support and steroidogenesis  388 
The reduced capacity of induced (Group B) CLs to produce P4 is consistent with the reduced 389 
expression of STAR and HSD3B1 observed (Table 4). Reduced expression of transcripts for 390 
IGFBP4 and increased expression of transcripts for IGFBP5 in Group C (regressing), relative to 391 
Group A (developing), CLs is consistent with earlier reports of CL demise following PGF2α 392 
induced luteolysis in cattle (Neuvians et al., 2003) and sheep (Hastie and Haresign, 2006). 393 
Whereas IGFBP4 generally inhibits IGF action, IGFBP5 is known to have both IGF-dependent 394 
and independent effects, but generally is associated with growth arrest and apoptosis (Kelley et 395 
al., 1996; Monget et al., 1998). What’s interesting in the current study is that transcript expression 396 
for these two binding proteins in Group B CLs more closely matches that of Group C than Group 397 
A CLs which, when considered with the P4 data in Table 2, lends further support to the 398 
functional inadequacy of these induced CLs. Closer inspection of Table 4 data, however, 399 
indicates that there are numerous molecular differences between Group B and C CLs, not least of 400 
which is transcript expression for steroidogenic enzymes and key cytokines, indicating that whilst 401 
these CLs may be developmentally compromised, they nevertheless retained some residual 402 
function.    403 
VEGFA is a potent mitogen that promotes the growth, migration and permeability of vascular 404 
endothelial cells in CLs throughout the luteal phase (Robinson et al., 2007). Levels of this protein 405 
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within the CL peak at around Day 15 of the oestrous cycle, but decline on luteolysis as witnessed 406 
in the current study (Table 4) and by Guzman et al. (2014). This latter study also demonstrated 407 
that there are both pro- and anti-angiogenic isoforms of VEGFA in the bovine CL, and that 408 
immediately prior to luteolysis there is an increase in anti-angiogenic isoforms.  With respect to 409 
the various isoforms identified by Guzman et al (2014), we can deduce from the primers designed 410 
for the current study that we amplified the single isoform 205; which has only been described as 411 
pro-angiogenic. Increased expression of this isoform in Group A CLs, relative to Groups B and C 412 
CLs, further serves to confirm their viability.  413 
Several alternatively spliced variants of the LHCGR gene have also been reported in the bovine 414 
ovary, but only a couple of these variants with open reading frames over the entire sequence are 415 
capable of producing a fully functional receptor (Robert et al., 2003). The variants reported 416 
include a complete deletion of exon 10 and/or partial deletion of exon 11; and there is also a loss 417 
of exon 3 in bovine granulosa cells (Nogueira et al., 2007). In humans, a splice variant lacking 418 
exon 10 produces a protein capable of binding hCG, but not LH (Müller et al., 2003) and, in 419 
keeping with a further human splice variant lacking exon 9, can form complexes with other 420 
LHCGR isoforms to reduce overall receptor expression and cAMP accumulation (Nakamra et al., 421 
2004; Ndiaye et al., 2005; Minegishi et al., 2007). Primer design in the current study (Table 1) 422 
allowed us to confirm expression of LHCGR transcripts lacking exons 3 and 9, but we were 423 
unable to detect transcripts lacking exon 10 in any of the somatic (i.e. granulosa, thecal and 424 
luteal) cells studied in the ovary. Relative to CLs from Group A (formed from ‘final-wave’ DFs), 425 
expression of all LHCGR variants was reduced in CLs from Group B (derived from first-wave 426 
DFs), and was barely detectable in regressing CLs (Group C) (Table 4). Based on quantitative 427 
measurements of LHCGR expression within the bovine CL during a regular oestrous cycle 428 
(Yoshioka et al., 2013), we surmise that Group B CLs in the current study were more similar to 429 
regular Day 2-3 CLs than Day 5-7 CLs. This point is consistent with reduced levels of P4 430 
production by Group B relative to Group A CLs (Table 2A).  431 
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Molecular features of DFs that give rise to CLs 432 
In the current study Group C DFs were more oestrogenic than Group A DFs (Table 2B), but 433 
transcript expression for ESR2, three steroidogenic enzymes (CYP11A1, HSD3B1 and CYP19A1), 434 
and subunits for inhibin-A and activin-A were decreased (Table 3A). These features are 435 
consistent with a number of previous observations. For example, increasing levels of LH (Byers 436 
et al., 1997) and ovarian oestrogens (Sharma et al., 1999) are each known to down-regulate ESR2 437 
expression in granulosa cells and, in cattle, levels of inhibin-A and activin-A in follicular fluid 438 
are reduced in large (13-20 mm) follicles with high (> 5) compared to low (< 5) E2:P4 ratios 439 
(Glister et al., 2006). Peripheral (Armstrong et al., 2001) and follicular (Echternkamp et al., 1994) 440 
concentrations of IGF1 also increase under these oestrogen-dominated conditions (Figure 3) as 441 
animals enter the follicular phase. Expression of uterine IGFBP2 mRNA and protein increases 442 
towards the late luteal phase and is thought to be under the regulation of P4 (McCarthy et al., 443 
2012; Costello et al., 2014). Elevated expression of IGFBP2 transcripts in Group C DFs (Table 3) 444 
and IGFBP2 protein in follicular-phase fluids (Figure 3) is consistent with these observations but, 445 
on first inspection, is somewhat at odds with earlier studies which indicate that IGFBP2 levels in 446 
follicular fluids decrease in large oestrogen-active and pre-ovulatory follicles (Enchternkamp et 447 
al., 1994; Funston et al., 1996). However, in contrast to previous work, the current study 448 
compared DFs of equivalent size but at different stages of the oestrous cycle. Furthermore, it is 449 
noteworthy that (i) follicles were harvested in both luteal and early follicular phases, and (ii) 450 
E2:P4 ratios were only slightly greater for Group C than Group A DFs (Table 2B) and were 451 
similar for abattoir derived early luteal- and early follicular-phase DFs (1.27 ± 0.96 vs 2.2 ± 1.50 452 
respectively). Western blot analyses also revealed proteolytic fragments of IGFBP2 in early 453 
follicular-phase DFs (data not shown), suggesting initial stages of degradation at the onset of this 454 
oestrogen-dominated period. Collectively, these data suggest the presence of an active IGF 455 
regulatory system in final wave DFs to tightly control cellular responses to increased circulating 456 
IGF1.  457 
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Conclusions 458 
The foregoing discussion focused on differences in functional competency and transcript 459 
expression of CLs derived following induced and spontaneous ovulations, together with 460 
differences in transcript expression of DFs that give rise to these structures. This study confirms 461 
that induced ovulation of a first-wave DF results in the formation of a smaller CL with 462 
functionally lower P4 production than one formed following spontaneous ovulation. Furthermore, 463 
these smaller induced CLs were characterised as having reduced expression of transcripts 464 
required for luteal support, angiogenesis and steroidogenesis, together with increased expression 465 
of transcripts associated with luteolysis. Importantly, these differences in CL function were not 466 
related to size of the ovulated DF, but were associated with their steroidogenic activity. 467 
Transcript expression differed between first- and final-wave DFs, and was associated with 468 
peripheral and local levels of P4 and components of the IGF system. These data indicate that 469 
these separate follicular systems interact to affect maturation of the ovulatory follicle transiting 470 
from di-oestrus to pro-oestrus in a manner that subsequently alters the functional competency of 471 
the CL.       472 
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Figure 1 Oestrous cycle manipulation timeline (A). Oestrous cycles of 24 Hereford x Holstein 1 
heifers were synchronised using prostaglandin (PG) and gonadotrophin releasing hormone 2 
(GnRH). Animals were given further injections according to their treatment group, indicated by 3 
letters A to C in brackets. Group A animals were slaughtered at Day 6 to recover a first wave 4 
dominant follicle (DF) and 6-day old corpus luteum (CL); Group B animals ovulated on Day 7 5 
and were slaughtered on Day 13 to recover a 6-day old induced CL; Group C animals were 6 
slaughtered on Day 19 to recover a final wave DF. Plasma progesterone was monitored from Day 7 
0 to slaughter for Group A (closed circles), B (open circles) and C (triangles) (B).  8 
Figure 2 Plasma IGF1 concentrations at the point of slaughter for 24 Hereford x Holstein heifers. 9 
Animals were synchronised (see Figure 1) then Group A animals slaughtered at Day 6 (after 10 
initial synchronised ovulation); Group B animals were induced to ovulate on Day 7 and 11 
slaughtered on Day 13; Group C animals were slaughtered on Day 19. Plasma IGF1 12 
concentrations were lower (P = 0.001) in Group A than in Group B and C animals. 13 
Figure 3 Follicular fluid IGFBP2 protein concentration (from cycle-stage determined abattoir 14 
derived ovaries) was greater (P < 0.001) in early follicular- than early luteal-phase dominant 15 
follicles (A). IGFBP2 was quantified by Western blotting. B, A typical gel for follicular fluid 16 
from two early luteal- (EL1 & EL2) and two early follicular (EF1 & EF2) phase-dominant 17 
follicles, with alternative lanes left blank (-). 18 
 19 
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Table 1A. Transcripts quantified in bovine dominant follicles and corpora lutea by GeXP. 
Gene Full Name 
Accession 
Number 
Primers 
TGF-β Superfamily   
AMH anti-Mullerian hormone NM_173890 
F: aggtgacactatagaatacgtgagctgagcgtagacct 
R: gtacgactcactatagggagacaggctgatgaggagctt 
BMP2 
bone morphogenetic 
protein (BMP) 2 
NM_001099141  
F: aggtgacactatagaataacttttggacaccaggttgg 
R: gtacgactcactatagggactaatccgcacatgcctctt 
BMP4 BMP 4 NM_001045877  
F: aggtgacactatagaatagcttccaccacgaagaacat 
R: gtacgactcactatagggatagtcgtgtgatgaggtgcc 
BMP6 BMP 6 XM_869844.3 
F: aggtgacactatagaatatgtcatgtgggcattttgtt 
R: gtacgactcactatagggaaccaacacaggagaagtggc 
BMPR1A BMP receptor, type IA NM_001076800  
F: aggtgacactatagaatagtgtgtgtgtgcatacgtgc 
R: gtacgactcactatagggaaatggcttttatgcgattgg 
BMPR1B BMP receptor, type IB NM_001105328 
F: aggtgacactatagaataatggaacagcagaggaatgc 
R: gtacgactcactatagggaaagtgccacggagaagaaaa 
BMPR2 BMP receptor, type II XM_617592               
F: aggtgacactatagaatacctgtcacacaataggcgtg 
R: gtacgactcactatagggactggacatcgaatgctcaga 
INHA inhibin, alpha NM_174094 
F: aggtgacactatagaatatagtgcaccctcccagtttc 
R: gtacgactcactatagggaggttgggcaccatctcatac 
INHBA inhibin, beta A NM_174363 
F: aggtgacactatagaataccaaagaaggcagtgacctg 
R: gtacgactcactatagggaagctggagacagggaagatg 
INHBB inhibin, beta B NM_176852 
F: aggtgacactatagaataagatcatcagcttcgccg 
R: gtacgactcactatagggacttcaggtagagccacaggc 
Insulin/IGF family   
IGF1 
insulin-like growth factor 
(IGF) 1 
NM_001077828 
F: aggtgacactatagaatagaagatgcccatcacatcct 
R: gtacgactcactatagggagcctcctcagatcacagctc 
IGF1R IGF 1 receptor XM_606794.3 F: aggtgacactatagaatacaaaggcaatctgctcatca 
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R: gtacgactcactatagggaagttcccctctagctgctcc 
IGF2 IGF 2 NM_174087 
F: aggtgacactatagaataacagcgagacacttgcagaa 
R: gtacgactcactatagggagacggtggtgactctgtgtg 
IGF2R IGF 2 receptor NM_174352 
F: aggtgacactatagaataggaccttctacctgagcgtg 
R: gtacgactcactatagggagttctggagctgaaaggtcg 
IGFBP2 IGF binding protein 2 NM_174555 
F: aggtgacactatagaatacaagggtggcaaacatcac 
R: gtacgactcactatagggagaggttgtacaggccatgct 
IGFBP4 IGF binding protein 4 NM_174557 
F: aggtgacactatagaatacaggctcccctttactcctc 
R: gtacgactcactatagggacctttctccatcaggcacat 
IGFBP5 IGF binding protein 5 NM_001105327.1 
F: aggtgacactatagaatagatcgaaagagactcccgtg 
R: gtacgactcactatagggagtcagcttctttctgcggtc 
INSR insulin receptor XM_590552 
F: aggtgacactatagaataaaagaggccccttaccagaa 
R: gtacgactcactatagggatgtacggcgttcatcagaaa 
Steroidogenic mediators   
CYP11A1 
cytochrome P450, family 
11, subfamily A, 
polypeptide 1 
NM_176644.2 
F: aggtgacactatagaataaagtttgacccaaccaggtg 
R: gtacgactcactatagggagtgtccacgtcaccgatatg 
CYP17A1 
cytochrome P450, family 
17, subfamily A, 
polypeptide 1 
NM_174304 
F: aggtgacactatagaataagacaaccaaaagggcattg 
R: gtacgactcactatagggaggcaggatcctcattcttga 
CYP19A1 
cytochrome P450, family 
19, subfamily A, 
polypeptide 1 
NM_174305 
F: aggtgacactatagaataaagccaagagcaacaagcat 
R: gtacgactcactatagggaatttggcgctaattccaaga 
ESR1 estrogen receptor 1 NM_001001443 
F: aggtgacactatagaataggtgtacatggacagcagca 
R: gtacgactcactatagggatccaggtaatagggcacctg 
ESR2 estrogen receptor 2 NM_174051 
F: aggtgacactatagaatagacagaccacaagcccaaat 
R: gtacgactcactatagggagtttcacgccaaggactctt 
HSD3B1 
2ydroxyl-delta-5-steroid 
dehydrogenase, 3 beta- 
and steroid delta-
isomerase 1 
NM_174343.2 
F: aggtgacactatagaatagcagaaaaccaaggagtgga 
R: gtacgactcactatagggaatcaccttgtctgtcccctg 
PGR progesterone receptor XM_583951.4 F: aggtgacactatagaatagttctcgctctacggggac 
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R: gtacgactcactatagggattgtacaggacgcactccag 
SCARB1 
scavenger receptor class 
B, member 1 
NM_174597.2 
F: aggtgacactatagaataacaaactgggaacatccagc 
R: gtacgactcactatagggagatggggatgagcagtagga 
LRP8 
low density lipoprotein 
receptor-related protein 8 
NM_001097565.1 
F: aggtgacactatagaataccctgcaagggttcatgtat 
R: gtacgactcactatagggagaaaatggcctcattctcca 
SHBG 
sex hormone-binding 
globulin 
NM_001098858  
F: aggtgacactatagaatacccagagtcattggaggcta 
R: gtacgactcactatagggagatcccaagtccgaaactca 
STAR 
steroidogenic acute 
regulatory protein 
NM_174189.2 
F: aggtgacactatagaatacctactgccaggaaagatgc 
R: gtacgactcactatagggaagaacctaggagagagccgc 
Cytokines   
IL1B interleukin (IL) 1, beta NM_174093.1 
F: aggtgacactatagaatatgaacccatcaacgaaatga 
R: gtacgactcactatagggatggatgtttccatctcccat 
IL2 IL 2 NM_180997.1 
F: aggtgacactatagaatacaaacggtgcacctacttca 
R: gtacgactcactatagggagaatccttgatctctctgggg 
IL6 IL 6 NM_173923.2 
F: aggtgacactatagaataagctctcattaagcgcatgg 
R: gtacgactcactatagggatctgcgatcttttgcttcag 
IL8 IL 8 NM_173925 
F: aggtgacactatagaataaccaatggaaacgaggtctg 
R: gtacgactcactatagggacctacaccagacccacacag 
KITLG KIT ligand NM_174375 
F: aggtgacactatagaataagcattgccagcattctttt 
R: gtacgactcactatagggagaactgttacccgccaatgt 
MIF 
macrophage migration 
inhibitory factor 
NM_001033608.1 
F: aggtgacactatagaatacaacttctgcgacatgaacg 
R: gtacgactcactatagggacgtttattgctccttccagg 
PTPRC 
protein tyrosine 
phosphatase receptor 
type C 
BC148881 
F: aggtgacactatagaatacggagatgcaggatcaaact 
R: gtacgactcactatagggacccagatcatcctccagaaa 
Apoptotic regulators   
CCND2 cyclin D2 NM_001076372.1 
F: aggtgacactatagaataagcagtaccgtcaggaccag 
R: gtacgactcactatagggaagagaaggagagagcggattg 
CFLAR 
CASP8 and FADD-like 
apoptosis regulator 
NM_001012281.1 F: aggtgacactatagaatactaaggctccagaatggcag 
Page 35 of 49
reproduction@bioscientifica.com
Manuscript submitted for review to Reproduction
For Review Only
R: gtacgactcactatagggagcttgacttcatagcccagg 
GADD45B 
growth arrest and DNA-
damage-inducible, beta 
NM_001040604.1 
F: aggtgacactatagaatatcacgaaccctcacacagac 
R: gtacgactcactatagggagtgttttccgcagcaagttt 
Angiogenic regulators   
HIF1A 
hypoxia-inducible factor 1, 
alpha subunit 
NM_174339.3 
F: aggtgacactatagaatatgcctctgaaactccaaagc 
R: gtacgactcactatagggactggggcatggtaaaagaaa 
VEGFA 
vascular endothelial 
growth factor A 
NM_174216.1 
F: aggtgacactatagaataagcaaggcaagaaaatccct 
R: gtacgactcactatagggatcctggtgagacgtctggtt 
Miscellaneous   
FGF1 fibroblast growth factor 1 NM_174055 
F: aggtgacactatagaatagtaacgcgcttctaaatgcc 
R: gtacgactcactatagggaatgagagggaatcatgccag 
FSHR FSH receptor NM_174061 
F: aggtgacactatagaataatgttttccagggagcctct 
R: gtacgactcactatagggatgacccctagcctgagtcat 
SFRS9 
splicing factor, 
arginine/serine-rich 9 
NM_001083398  
F: aggtgacactatagaataatatgccctgcgtaaactgg 
R: gtacgactcactatagggaattcccaccacctgtctcag 
PGF2AR 
Prostaglandin F2α 
receptor 
BD187584 
F: aggtgacactatagaatatgcccactttttctaggcag  
R: gtacgactcactatagggaatggcattgcaaacaaatga 
House-keeping genes   
GAPDH 
glyceraldehyde-3-
phosphate dehydrogenase 
NM_001034034  
F: aggtgacactatagaatacaccctcaagattgtcagca 
R: gtacgactcactatagggaggtcataagtccctccacga 
H2AZ 
H2A histone family, 
member Z 
NM_174809.2 
F: aggtgacactatagaatatccagtgttggtgattccag 
R: gtacgactcactatagggatttggttggttggaaagctaa 
RPLP0 
ribosomal protein, large, 
P0 
NM_001012682.1 
F: aggtgacactatagaatacttgctgaaaaggtcaaggc 
R: gtacgactcactatagggagactcctccgactcctcctt 
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Table 1B. Primers designed to amplify regions of the luteinizing hormone/chorionic 
gonadotrophin receptor (LHCGR) (NM_174381) by GeXP 
Product name Product Location Primers 
LHCGRex2 exons 2-4 
F: aggtgacactatagaatacacctatctccctatcaaagtaatcc 
R: gtacgactcactatagggacgagggagatttgtaaacgc 
LHCGRex8 exons 8-11 
F: aggtgacactatagaatagagctgaaggaaaatgcacg 
R: gtacgactcactatagggaggagtgtcttgggtaagcaga 
LHCGRex11 within exon 11 
F: aggtgacactatagaatatgttaggcacatcaggcaaa 
R: gtacgactcactatagggaccatgttcatggattggaag 
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Table 2. Structures present on the ovaries of heifers at slaughter. Group A were slaughtered 
at day 6 after synchronised ovulation; Group B were given prostaglandin and GnRH on day 6 
to induce CL regression and ovulation on day 7 and were slaughtered on day 13; Group C 
were slaughtered on day 19. 
A. Size of the dominant follicle (DF), and size and mass of the corpus luteum (CL), together 
with progesterone production 
 
Treatment Group 
Probability 
A (n=8) B (n=7) C (n=8) 
DF     
Diameter (mm) 15.12 ± 0.85 16.57 ± 0.61 14.75 ± 0.65 - 
CL     
Diameter (mm) 23.88 ± 1.89
a
 18.14 ± 1.03
b
 21.00 ± 0.53
ab
 0.021 
Mass  (g) 6.36 ± 1.47
a
 2.94 ± 0.44
b
 3.92 ± 0.29
ab
 0.049 
Total P4 content (mg) 209 ± 81
a 
31 ± 8
b 
49 ± 8
b 
0.035 
P4  production (ng/25 mg tissue) 771 ± 161
a 
191 ± 54
b 
102 ± 35
b 
<0.001 
P4 synthetic capacity (mg/CL) 163 ± 36
a 
23 ± 8
b 
17 ± 6
b 
<0.001 
 
B. Oestradiol and progesterone concentrations in follicular fluids from dominant (DF), largest 
subordinate (SF) and a selection of small (2-6mm) subordinate follicles 
 
Follicle Class 
Treatment Group 
Probability 
 A (n=8) B (n=7) C (n=8) 
E2 
(ng/ml) 
DF 181.4 ± 103.5 576.9 ± 109.6 407.2 ± 109.5 0.056 
Small 0.60 ± 0.75 2.56 ± 0.75 1.43 ± 0.76 - 
SF 7.93 ± 7.42 3.51 ± 9.82 15.12 ± 7.42 - 
P4 
(ng/ml) 
DF 81.5 ± 11.3 67.3 ± 13.0 75.7 ± 11.3 - 
Small 284.3 ± 56.3 197.5 ± 56.5 85.7 ± 56.3 0.058 
SF 274.9 ± 116.2 234.5 ± 124.2 275.6 ± 116.2 - 
E2:P4 
Ratio 
DF 2.55 ± 1.60 8.98 ± 1.65 6.01 ± 1.65 0.054 
Small 0.004 ± 0.003 0.022 ± 0.008 0.020 ± 0.007 - 
SF 0.25 ± 0.20 0.009 ± 0.17 0.40 ± 0.21 - 
Values are given as mean ± SE, letters in superscript indicate significant differences 
(P<0.05). 
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Table 3. Transcript expression in first wave (A), first wave in the presence of a sub-
functional corpus luteum (B) and final wave (C) bovine dominant follicles. In general, only 
transcripts that differed significantly between treatment groups are shown. 
A. Granulosa cells  
Transcript 
Treatment Group 
Probability 
A (n=8) B (n=7) C (n=8) 
TGF-β Superfamily    
INHA 0.281 ± 0.026
a
 0.272 ± 0.046
a
 0.132 ± 0.043
b
 0.020 
INHBA 0.948 ± 0.060
a
 0.769 ± 0.093
ab
 0.500 ± 0.132
b
 0.015 
Insulin/IGF family    
IGF2R 0.100 ± 0.012 0.092 ± 0.009 0.159 ± 0.037 0.122 
IGFBP2 0.200 ± 0.029 0.166 ± 0.014 0.353 ± 0.086 0.059 
Steroidogenic mediators    
CYP11A1 0.545 ± 0.048
a 
0.462 ± 0.050
a 
0.273 ± 0.079
b 
0.015 
CYP19A1 2.955 ± 0.145
a
 2.411 ± 0.121
a
 1.195 ± 0.315
b
 <0.001 
ESR2 0.231 ± 0.029
a
 0.199 ± 0.025
ab
 0.123 ± 0.024
b
 0.024 
HSD3B1 0.229 ± 0.028
a
 0.205 ± 0.025
ab
 0.112 ± 0.038
b
 0.036 
SCARB1 0.433 ± 0.062 0.492 ± 0.062 0.2839 ± 0.066 0.083 
Angiogenic regulators    
HIF1A 0.984 ± 0.053
a 
0.951 ± 0.064
a 
0.668 ± 0.091
b 
0.009 
Miscellaneous 
  
 
PGF2AR 0.034 ± 0.004
a
 0.025 ± 0.007
ab
 0.013 ± 0.005
b
 0.038 
SFRS9 0.601 ± 0.037 0.569 ± 0.031 0.493 ± 0.032 0.079 
B. Thecal cells 
Transcript 
Treatment Group 
Probability 
A (n=8) B (n=7) C (n=8) 
Insulin/IGF family    
IGF2R 0.080 ± 0.009
a
 0.102 ± 0.014
ab
 0.136 ± 0.012
b
 0.011 
IGFBP2 0.211 ± 0.028
a
 0.216 ± 0.045
a
 0.366 ± 0.053
b
 0.030 
Steroidogenic mediators    
SCARB1 0.272 ± 0.048
a
 0.535 ± 0.073
b
 0.505 ±0.099
b
 0.047 
Cytokines    
PTPRC 0.044 ± 0.006
a
 0.048 ± 0.007
a
 0.094 ± 0.017
b
 0.011 
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Values are mean ± SE in arbitrary fluorescence units relative to the control genes GAPDH, 
H2AZ and RPLP0. Letters in superscript indicate significant differences (P<0.05). Reported 
transcripts (other than IGF2R in granulosa cells) lie within the FDR threshold of 0.25.   
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Table 4. Transcript expression in six-day old spontaneous (A), six day old induced (B) and 19 1 
day old regressing (C) bovine corpora lutea. Only transcripts that differed between treatment 2 
groups are shown. Abundance of three regions (LHCGRex11, LHCGRex2 and LHCGRex8) with 3 
two splice variants lacking exon three (LHCGRex2(-3)) and exon nine (LHCGRex8(-9)) of the 4 
LHCGR transcript is given. 5 
 6 
Transcript 
Treatment Group 
Probability 
A (n=8) B (n=7) C (n=8) 
TGF-β Superfamily    
BMP2 0.003 ± 0.002
a
 0.021 ± 0.006
b
 0.020 ± 0.006
b
 0.037 
INHBA 0.017 ± 0.006
a
 0.039 ± 0.013
ab
 0.063 ± 0.009
b
 0.009 
INHBB 0.016 ± 0.004
a
 0.038 ± 0.016
ab
 0.063 ± 0.012
b
 0.027 
Insulin/IGF family    
IGFBP4 0.228 ± 0.037
a
 0.116 ± 0.016
b
 0.134 ± 0.031
b
 0.038 
IGFBP5 0.266 ± 0.022
a
 0.550 ± 0.086
b
 0.635 ± 0.121
b
 0.016 
Steroidogenic mediators    
CYP11A1 0.933 ± 0.065
a 
0.720 ± 0.126
a 
0.466 ± 0.036
b 
0.002 
HSD3B1 0.637 ± 0.032
a
 0.415 ± 0.126
b
 0.078 ± 0.024
c
 <0.001 
SCARB1 1.722 ± 0.092
a
 1.493 ± 0.210
a
 1.038 ± 0.085
b
 0.005 
STAR 1.350 ± 0.061
a
 0.837 ± 0.185
b
 0.266 ± 0.053
c
 <0.001 
Cytokines 
   
 
IL1B 0.307 ± 0.027
a 
0.246 ± 0.026
ab 
0.182 ± 0.025
b 
0.011 
IL8 0.039 ± 0.010
a
 0.062 ± 0.013
a
 0.166 ± 0.038
b
 0.004 
KITLG 0.046 ± 0.008
a
 0.024 ± 0.004
b
 0.002 ± 0.004
c
 <0.001 
MIF 0.037 ± 0.003
a 
0.034 ± 0.006
a 
0.012 ± 0.004
b 
<0.001 
Apoptotic regulators    
GADD45B 0.444 ± 0.028
a
 0.295 ± 0.040
b
 0.231 ± 0.034
b
 <0.001 
Angiogenic regulators
   
 
HIF1A 0.674 ± 0.034
a 
0.612 ± 0.039
ab 
0.441 ± 0.047
b 
0.002 
VEGFA 0.037± 0.009
a 
0.009 ± 0.005
b 
ND 0.002 
Miscellaneous
   
 
PGF2AR  0.500 ± 0.045
a 
 0.304 ± 0.056
b
 0.144 ± 0.036
c
 <0.001 
SFRS9 0.579 ± 0.046 0.621 ± 0.027 0.479 ± 0.042 0.075 
Luteinizing hormone receptor variants    
LHCGRex2 0.392 ± 0.054
a
 0.218 ± 0.085
b
 0.003 ± 0.002
c
 <0.001 
LHCGRex2(-3) 0.059 ± 0.012
a
 0.017 ± 0.010
b
 ND <0.001 
LHCGRex8 0.012 ± 0.007 ND ND - 
LHCGRex8(-9) 0.019 ± 0.009 ND ND - 
LHCGRex11 0.428 ± 0.048
a
 0.281 ± 0.137
a
 0.001 ± 0.001
b
 0.003 
Values are mean ± SE in arbitrary fluorescence units relative to the control genes GAPDH, 7 
H2AZ and RPLP0. Letters in superscript indicate significant differences (P<0.05), ND means 8 
none detected. Reported transcripts lie within the FDR threshold of 0.25.   9 
 10 
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Supplementary Information 
Supplementary Materials and Results 
To develop the GeXP platform for our study, RNA was extracted from a mixture of cells (i.e. 
aspirated and scrapped bovine follicles of varying size, plus sonicated CL tissue). These mixed 
cell populations included oocytes. This phase of the study concerned GeXP primer design. All 
genes in the master list (Table 1 of manuscript) were detected.   
For GeXP validation, ESR2 and HIF1A were chosen at random and quantified by quantitative, 
real time PCR (qRT-PCR) and by GeXP. Granulosa cells were collected from a selection of 10-
14 mm diameter, abattoir derived bovine dominant follicles. 12µl of mRNA, extracted and 
purified as described in the materials and methods, was denatured at 70
o
C for 10 minutes using a 
thermal cycler (BioRad, Hemel-Hempstead, Hertfordshire, UK). Reverse transcription (RT) was 
performed at 37
o
C for 60 minutes using an Omniscript RT Kit (Qiagen Ltd., Crawley, West 
Sussex, UK) with RNase inhibitor (Bioline Ltd., London, UK). 1µl of the resulting cDNA was 
added to a PCR reaction mixture including SYBR Green (Applied Biosystems, Warrington, 
Cheshire, UK) and 20µM forward and reverse primers. The PCR reaction was performed within a 
LightCycler 480 (Roche Diagnostics GmBH, Mannheim, Germany) using the following program: 
Quantification – 1 cycle of 95
o
C for 10 minutes; 35 cycles of 95
o
C for 30 seconds, 60
o
C for 90 
seconds, 72
o
C for 10 seconds; Melting – 95
o
C for 5 seconds; 65
o
C for 1 minute; Cooling – 40
o
C 
for 30 seconds. LightCycler 480 software was used to normalise expression relative to the house-
keeping gene H2AZ, interpret and analyse the results. The same samples were also quantified by 
GeXP, as described in the materials and methods.  
GeXP and qRT-PCR determined expression of ESR2 and HIF1A was correlated (R
2
=0.515, 
P<0.001 and R
2
=0.453, P=0.006, respectively) (Supplementary Figure 1) so confirming GeXP as 
a suitable method for the quantification of gene expression. 
Genes not expressed in experimental cells 
Transcripts for all genes described in Table 1 of the manuscript (including those listed below) 
were expressed in a mixed population of cells during GeXP platform development. These cells 
were harvested from a mixed sample of abattoir derived CLs and follicles at various antral-stages 
of development (from 2 mm in diameter). Below we describe expression patterns and functions 
for those genes not detected in our experimental granulosa, theca and luteal cells. In some cases 
this may have arisen as a consequence of primer design and splice variant expression, because 
bovine variants for these genes are poorly described in the literature. 
AMH: Important during pre-antral follicle development, regulating both the transition from 
primordial to primary follicle stages, and the response to FSH (Knight and Glister, 2006). 
Transcript expression for AMH is restricted to granulosa cells (Vigier et al., 1984; Takahashi et 
al., 1986) and declines beyond the early antral stages of follicle development, and is further 
reduced in granulosa cells from atretic follicles (Rico et al., 2009). Interestingly, blood AMH 
concentrations are also at their lowest between Days 4 and 6 of the oestrous cycle (Rico et al., 
2011) when Group A animals were slaughtered in our study. Collectively these results may 
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explain why we did not detect AMH transcripts in selected somatic cells of the bovine ovary in 
the current study.  
BMP6:  Expressed and active in bovine granulosa and thecal cells at least up to approximately 6 
mm in diameter where it can attenuate the actions of both FSH and forskolin in vitro (Kayani et 
al., 2009; Glister et al., 2013). BMP6 mRNA is lost during selection of the dominant follicle in 
the rat (Erickson and Shimasaki, 2003), although transcripts for this transforming growth factor-
beta superfamily member have been detected within the bovine CL (Kayani et al., 2009) and 
follicle up to 18 mm in diameter (Glister et al., 2010). Established actions of BMP6 on bovine 
ovarian follicular cells have largely been confined to in vitro culture with cells from follicles < 6 
mm in diameter. Inability to detect transcripts for BMP6 in the current study could have been due 
to low expression, especially in granulosa cells (Glister et al., 2010).  
FGF1:  Transcripts for this fibroblast growth factor have previously been reported in theca and 
granulosa cells from antral (5 to 14 mm) follicles derived from abattoir recovered bovine ovaries 
(Berisha et al., 2004). Expression was relatively greater in theca than granulosa cells in that study 
and did not vary significantly between follicle size classes. FGF1 is generally known to exert 
mitogenic, anti-apoptotic and angiogenic effects in a variety of tissues. In cultured bovine 
granulosa cells (harvested from 2-5 mm follicles) FGF1 increased expression of Sprouty family 
members (SPRY2 and SPRY4), as well as orphan nuclear receptors (NR4A1 and NR4A3), thereby 
confirming functional activity in these cells (Jiang and Price, 2012).  Inability to detect transcripts 
for FGF1 in the current study could have also been due to low expression, again especially in 
granulosa cells.  
IL6 and IL2: Interleukin-6 is a pro-inflammatory cytokine involved in a variety of roles 
(including anti-apoptotic) within the ovary associated with ovulation, CL formation and demise 
(Bornstein et al., 2004; Richards et al., 2008). IL6 is produced predominantly by macrophages 
and activated T cells within the CL, particularly during luteolysis. IL6 mRNA expression is often 
barely detectable in the CL, with inhibition stemming from locally produced progesterone 
(Telleria et al., 1998). Similarly, Petroff et al. (1999) failed to detect transcripts for IL2 in the 
bovine CL at various stages of the luteal phase. However, interleukins are inducible. For 
example, exposure of bovine granulosa cells to lipopolysaccharide led to a rapid and sustained 
increase in transcripts for IL6 in cultured bovine granulosa cells (Bromfield and Sheldon, 2011). 
It’s possible that the necessary conditions for induction may have been absent in our cells.   
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. 
Supplementary Figure 1 A comparison of GeXP and qRT-PCR determined ESR2 (A) and 
HIF1A (B) transcript expression in granulosa cells from bovine dominant ovarian follicles 
collected from a local abattoir. Expression is given in arbitrary fluorescence units relative to 
house-keeping gene expression (GAPDH, H2AZ and RPLP0 for GeXP; H2AZ for qRT-PCR). 
 
 
Supplementary Figure 2 LHCGR transcripts, control genes (GAPDH, H2AZ and RPLP0) 
and internal standard (Kan
r
) peaks detected using GeXP  in granulosa cells from a sample of 
abattoir derived early luteal dominant follicles (A). Smaller fragments of the LHCGR with 
missing exons (indicated in brackets) were identified alongside three complete fragments (B) 
(not to scale). 
 
 
Supplementary Figure 3. Relationships between ovulatory dominant follicle (DF) and 6-day 
old  corpus luteum (CL) diameter (A), and CL diameter and progesterone (P4) synthesis (B). 
All DFs were scanned on experimental Day -1 (•) and the resulting CL were measured on 
experimental Day 6 by ultrasonography (Groups B and C) or following dissection (Group A). 
DFs present in Group B were scanned on experimental Day 6 (○) and the resultant CL 
measured following dissection on experimental Day 13. Day -1 DFs were positively 
correlated (r = 0.63; P = 0.001) with Day 6 CL diameter, whereas Day 6 DFs were not 
significantly correlated with Day 13 CL diameter. There was no significant difference in 
mean diameter between Day -1 and Day 6 DFs (13.4 vs 12.0 mm; P = 0.09). There was no 
relationship (r = 0.17; NS) between CL diameter and P4 synthesis for either Group A or B 
treatments.  
 
 
Supplementary Figure 4. Ovarian follicular growth and plasma progesterone (P4) 
concentrations (ng/ml) in eight Group C Hereford x Holstein heifers following synchronised 
oestrus (ovulation occurred between 11 am on Day -1 and 11 am on Day +1), as determined 
by trans-rectal ultrasonography. Heifers 230 and 260 had not ovulated when initially scanned 
early on Day +1 but had later that morning. Solid black lines indicate ovulated dominant 
follicles (DFs) (heifers 230 and 260) and DFs present at slaughter. Coloured dashed lines 
indicate other DFs. Grey dotted lines indicate all other follicles greater than 4 mm in 
diameter. Plasma P4 concentrations are illustrated by yellow shading. 
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